Infliximab in the Treatment of Patients With Severe COVID-19 Disease
Clinical trial NCT04922827 · COMPLETED
Trial details
- NCT number
- NCT04922827
- Sponsor
- Jena University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-18
- Primary completion
- 2023-03-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.